{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:26:50Z","timestamp":1762100810778},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":6875,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[1989,9]]},"abstract":"<jats:p>The minimal inhibitory concentrations (<jats:italic>MIC<\/jats:italic>) of five tetracyclines and ten other antimicrobial agents were determined for four porcine bacterial respiratory tract pathogens by the agar dilution method. For the following oxytetracycline\u2010susceptible strains, the <jats:italic>MIC<\/jats:italic><jats:sub>50<\/jats:sub> ranges of the tetracyclines were: <jats:italic>P. multocida<\/jats:italic> (<jats:italic>n<\/jats:italic>= 17) 0.25\u20130.5 \u03bcg\/ml; <jats:italic>B. bronchiseptica<\/jats:italic> (<jats:italic>n<\/jats:italic>= 20) 0.25\u20131.0 \u03bcg\/ml; <jats:italic>H. pleuropneumoniae<\/jats:italic> (<jats:italic>n<\/jats:italic>= 20) 0.25\u20130.5 \u03bcg\/ml; <jats:italic>S. suis<\/jats:italic> Type 2 (<jats:italic>n<\/jats:italic>= 20) 0.06\u20130.25 \u03bcg\/ml. For 19 oxytetracycline\u2010resistant <jats:italic>P. multocida<\/jats:italic> strains the <jats:italic>MIC<\/jats:italic><jats:sub>50<\/jats:sub> of the tetracyclines varied from 64 \u03bcg\/ml for oxytetracycline to 0.5 \u03bcg\/ml for minocycline. Strikingly, minocycline showed no cross\u2010resistance with oxytetracycline, tetracycline, chlortetracycline and doxycycline in <jats:italic>P. multocida<\/jats:italic> and in <jats:italic>H. pleuropneumoniae.<\/jats:italic> Moreover, in susceptible strains minocycline showed the highest <jats:italic>in vitro<\/jats:italic> activity followed by doxycycline. Low <jats:italic>MIC<\/jats:italic><jats:sub>50<\/jats:sub> values were observed for chloramphenicol, ampkillin, flumequine, ofloxacin and ciprofloxacin against <jats:italic>P. multocida<\/jats:italic> and <jats:italic>H. pleuropneumoniae. B. bronchiseptica<\/jats:italic> was moderately susceptible or resistant to these compounds. As expected tiamulin, lindomycin, tylosin and spiramycin were not active against <jats:italic>H. pleuropneumoniae.<\/jats:italic> Except for flumequine, the <jats:italic>MIC<\/jats:italic><jats:sub>50<\/jats:sub> values of nine antimicrobial agents were low for <jats:italic>S. suis<\/jats:italic> Type 2. Six strains of this species showed resistance to the macrolides and lincomycin.<\/jats:p>","DOI":"10.1111\/j.1365-2885.1989.tb00670.x","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T10:55:18Z","timestamp":1208429718000},"page":"267-276","source":"Crossref","is-referenced-by-count":37,"title":["<i>In vitro<\/i> activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens"],"prefix":"10.1111","volume":"12","author":[{"given":"A.","family":"PIJPERS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. VAN","family":"KLINGEREN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"SCHOEVERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H. M.","family":"VERHEIJDEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.J. P. A. M. VAN","family":"MIERT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1061","article-title":"Pharmacotherapeutics of the newer tetracyclines","volume":"176","author":"Aronson A.L.","year":"1980","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(80)80247-6"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/jcm.21.6.880-883.1985","article-title":"Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5\u2010mcg disks","volume":"21","author":"Barry A.L.","year":"1985","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.8.6.713"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.119.5.108"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.7.3.227"},{"key":"e_1_2_1_8_1","first-page":"716","article-title":"Porcine Haemophilus pleuropneumoniae: microbiologic and pathologic findings","volume":"184","author":"Didier P.L.","year":"1984","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_1_9_1","first-page":"47","article-title":"Antimicrobial susceptibility of 51 strains of Haemophilus pleuropneumoniae","volume":"48","author":"Gilbride K.A.","year":"1984","journal-title":"Canadian Journal of Comparative Medicine"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/00480169.1984.35085"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.1986.9694024"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms1939.46.175"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01975473"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(87)90087-3"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0147-9571(85)90055-4"},{"key":"e_1_2_1_16_1","first-page":"1640","article-title":"Lancefield group R Streptococci associated with pneumonia in swine","volume":"40","author":"Koehne G.","year":"1979","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_17_1","volume-title":"Diseases of Swine","author":"Kunesh J.P.","year":"1986"},{"key":"e_1_2_1_18_1","first-page":"399","article-title":"Antimicrobial sensitivity patterns of Haemophilus pleuropneumoniae isolates from pigs with pneumoniae","volume":"180","author":"Libal M.C.","year":"1982","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.5.791"},{"key":"e_1_2_1_20_1","volume-title":"Antimicrobial Drug Resistance","author":"Mitsuhashi S.","year":"1984"},{"key":"e_1_2_1_21_1","first-page":"129","article-title":"Microorganisms associated with pneumonia in slaughter weight swine","volume":"49","author":"Morrison R.B.","year":"1985","journal-title":"Canadian Journal Comparative Medicine"},{"key":"e_1_2_1_22_1","unstructured":"Mouton B.P.&vanKlingeren B.(1985)The Standardization of Susceptibility Tests(in Dutch). Report of the working party on guidelines for susceptibility testing. National Institute of Public Health and Environmental Hygiene Bilthoven the Netherlands. ISBN 90\u20136960\u2013001\u20133."},{"key":"e_1_2_1_23_1","unstructured":"Nicolet J.&Schifferli D.(1982)In\u2010vitrosusceptibility ofHaemophilus pleuropneumoniaeto antimicrobial substances.Proceedings of the 7th Congress IPVS Mexico City p.71."},{"key":"e_1_2_1_24_1","first-page":"868","article-title":"Bacteria and their Antibiograms","volume":"106","author":"Overgoor G.H.A.","year":"1981","journal-title":"Netherlands Journal Veterinary Science"},{"key":"e_1_2_1_25_1","volume-title":"Manual of Clinical Microbiology","author":"Paik G.","year":"1980"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(87)90043-5"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.108.21.451"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)32225-2"},{"key":"e_1_2_1_29_1","unstructured":"Scheer M. Bauditz R.&Linke H.(1986)Bay VP 2674 (Baytril\u00ae): Antibacterial activity as well as serum and tissue levels in pigs.Proceedings 9th Congress IPVS Barcelona p.458."},{"key":"e_1_2_1_30_1","first-page":"604","article-title":"Antibiotic and sulfonamide sensitivity of 50 Haemophilus pleuropneumoniae isolates","volume":"78","author":"Schultz R.A.","year":"1983","journal-title":"Veterinary Medicine"},{"key":"e_1_2_1_31_1","first-page":"1331","article-title":"Haemophilus pleuropneumoniae infection in swine: a review","volume":"182","author":"Sebunya T.N.K.","year":"1983","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1981.tb00081.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms1939.44.359"},{"key":"e_1_2_1_34_1","first-page":"703","article-title":"Minimum inhibitory concentrations of antibacterial agents against strains of Haemophilus pleuropneumoniae from swine","volume":"79","author":"Sidoli L.","year":"1984","journal-title":"Veterinary Medicine"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.106.22.462"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000441-196803000-00005","article-title":"Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro","volume":"255","author":"Steigbigel N.H.","year":"1968","journal-title":"American Journal of Medical Science"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.3.5.555"},{"key":"e_1_2_1_38_1","first-page":"622","article-title":"Long\u2010term effect of Bordetella bronchiseptica infection in neonatal pigs","volume":"43","author":"Underdahl N.R.","year":"1982","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.1985.9694005"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1983.tb00451.x"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1986.tb00027.x"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.1989.tb00670.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.1989.tb00670.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T04:43:14Z","timestamp":1697949794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.1989.tb00670.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,9]]}},"alternative-id":["10.1111\/j.1365-2885.1989.tb00670.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.1989.tb00670.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,9]]}}}